EADV 2026
Child Chronic Inducible Urticaria: Is It Possible to Control?
A prospective single-centre observational series of omalizumab in paediatric chronic
Saif Quadri
October 27, 2026
A prospective single-centre observational series of omalizumab in paediatric chronic
An assessment of where endotype-directed prescribing now stands following two
A guideline-focused teaching lecture covering classification, diagnostic work-up and treat-to-target
An expert overview of pathomechanism and the emerging therapeutic pipeline,
An expert overview of pathomechanism and the emerging therapeutic pipeline,
SETTING THE SCENE JAK1 inhibition in AD has been validated
SETTING THE SCENE Both JAK1 inhibitors and dupilumab produce impressive
SETTING THE SCENE Facial AD in children with skin of
SETTING THE SCENE The 2% crisaborole formulation is one of
A systematic review and meta-analysis presented at the 2026 ACOG
A large population-based study presented at the 2026 ACOG Scientific
A quality improvement initiative presented at the 2026 ACOG Scientific